A private family office led a $20m Series A round in Method AI.

A private family office, led a $20m Series A round in Method AI, a B2B technology company, with participation from Cleveland Clinic and JobsOhio Growth Capital Fund. "In complex oncology procedures, surgeons often have to remove tumors that are partially or completely embedded within the organ, making it extremely difficult to gauge the margins of the tumor during a live surgery. With the support of our investment partners, our technology can make the difference between completely removing a tumor or leaving part of it behind, which significantly impacts long-term patient outcomes," Doug Teany, Method AI Co-Founder and CEO.